LEMAITRE VASCULAR, INC. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
LEMAITRE VASCULAR, INC. (LMAT) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $2.81 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-08-05
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.81M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $4.15M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.34M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.78M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year as first filed |
|---|---|---|
| 2026-06-30 | $2.81M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $4.15M 10-Q · filed 2026-05-06 | |
| 2025-09-30 | $1.34M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $2.78M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $4.15M 10-Q · filed 2025-05-08 | |
| 2024-09-30 | $1.45M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $2.91M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $4.38M 10-Q · filed 2024-05-10 | |
| 2023-09-30 | $1.49M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $2.98M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $4.49M 10-Q · filed 2023-05-09 | |
| 2022-09-30 | $1.53M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $3.07M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $4.50M 10-Q · filed 2022-05-10 | |
| 2021-09-30 | $1.50M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $3.05M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $4.61M 10-Q · filed 2021-05-10 | |
| 2020-09-30 | $1.60M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $3.15M 10-Q · filed 2020-08-06 | |
| 2019-09-30 | $573.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.01M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.59M 10-Q · filed 2019-05-06 | |
| 2017-06-30 | $904.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.31M 10-Q · filed 2017-05-04 | |
| 2016-09-30 | $372.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $745.00K 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $1.16M 10-Q · filed 2016-05-06 | |
| 2015-09-30 | $365.00K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $740.00K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.03M 10-Q · filed 2015-05-07 | |
| 2014-09-30 | $435.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $659.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.01M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $939.00K 10-Q · filed 2013-05-08 | |
| 2013-09-30 | $356.00K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $651.00K 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $194.00K 10-Q · filed 2012-11-09 | $387.00K 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |